187 related articles for article (PubMed ID: 29771164)
1. Retrospective Evaluation of Clinical Experience With Intravenous Ascorbic Acid in Patients With Cancer.
Bazzan AJ; Zabrecky G; Wintering N; Newberg AB; Monti DA
Integr Cancer Ther; 2018 Sep; 17(3):912-920. PubMed ID: 29771164
[TBL] [Abstract][Full Text] [Related]
2. The safety and pharmacokinetics of high dose intravenous ascorbic acid synergy with modulated electrohyperthermia in Chinese patients with stage III-IV non-small cell lung cancer.
Ou J; Zhu X; Lu Y; Zhao C; Zhang H; Wang X; Gui X; Wang J; Zhang X; Zhang T; Pang CLK
Eur J Pharm Sci; 2017 Nov; 109():412-418. PubMed ID: 28847527
[TBL] [Abstract][Full Text] [Related]
3. Intravenous Vitamin C and Cancer: A Systematic Review.
Fritz H; Flower G; Weeks L; Cooley K; Callachan M; McGowan J; Skidmore B; Kirchner L; Seely D
Integr Cancer Ther; 2014 Jul; 13(4):280-300. PubMed ID: 24867961
[TBL] [Abstract][Full Text] [Related]
4. The timeliness of patients reporting the side effects of chemotherapy.
Olver I; Carey M; Boyes A; Hall A; Noble N; Bryant J; Walsh J; Sanson-Fisher R
Support Care Cancer; 2018 Oct; 26(10):3579-3586. PubMed ID: 29725799
[TBL] [Abstract][Full Text] [Related]
5. Intravenous vitamin C administration improves quality of life in breast cancer patients during chemo-/radiotherapy and aftercare: results of a retrospective, multicentre, epidemiological cohort study in Germany.
Vollbracht C; Schneider B; Leendert V; Weiss G; Auerbach L; Beuth J
In Vivo; 2011; 25(6):983-90. PubMed ID: 22021693
[TBL] [Abstract][Full Text] [Related]
6. High-dose intravenous vitamin C combined with cytotoxic chemotherapy in patients with advanced cancer: a phase I-II clinical trial.
Hoffer LJ; Robitaille L; Zakarian R; Melnychuk D; Kavan P; Agulnik J; Cohen V; Small D; Miller WH
PLoS One; 2015; 10(4):e0120228. PubMed ID: 25848948
[TBL] [Abstract][Full Text] [Related]
7. Effects of ghrelin administration during chemotherapy with advanced esophageal cancer patients: a prospective, randomized, placebo-controlled phase 2 study.
Hiura Y; Takiguchi S; Yamamoto K; Takahashi T; Kurokawa Y; Yamasaki M; Nakajima K; Miyata H; Fujiwara Y; Mori M; Kangawa K; Doki Y
Cancer; 2012 Oct; 118(19):4785-94. PubMed ID: 22282373
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of moderately emetogenic chemotherapy or anthracycline and cyclophosphamide regimens in patients with cancer: a randomised, active-controlled, double-blind, phase 3 trial.
Schwartzberg LS; Modiano MR; Rapoport BL; Chasen MR; Gridelli C; Urban L; Poma A; Arora S; Navari RM; Schnadig ID
Lancet Oncol; 2015 Sep; 16(9):1071-1078. PubMed ID: 26272768
[TBL] [Abstract][Full Text] [Related]
9. Effect on symptom control of structured information given to patients receiving chemotherapy.
Mollaoğlu M; Erdoğan G
Eur J Oncol Nurs; 2014 Feb; 18(1):78-84. PubMed ID: 24095215
[TBL] [Abstract][Full Text] [Related]
10. Relief from cancer chemotherapy side effects with pharmacologic vitamin C.
Carr AC; Vissers MC; Cook J
N Z Med J; 2014 Jan; 127(1388):66-70. PubMed ID: 24481389
[TBL] [Abstract][Full Text] [Related]
11. Changes of terminal cancer patients' health-related quality of life after high dose vitamin C administration.
Yeom CH; Jung GC; Song KJ
J Korean Med Sci; 2007 Feb; 22(1):7-11. PubMed ID: 17297243
[TBL] [Abstract][Full Text] [Related]
12. Adjusting the dose of intravenous ondansetron plus dexamethasone to the emetogenic potential of the chemotherapy regimen.
Hesketh PJ; Beck T; Uhlenhopp M; Kris MG; Hainsworth JD; Harker WG; Cohen JR; Lester E; Kessler JF; Griffen D
J Clin Oncol; 1995 Aug; 13(8):2117-22. PubMed ID: 7636556
[TBL] [Abstract][Full Text] [Related]
13. Severity and predictive factors of adverse events in pemetrexed-containing chemotherapy for non-small cell lung cancer.
Miyahara T; Sueoka-Aragane N; Iwanaga K; Ureshino N; Komiya K; Nakamura T; Nakashima C; Abe T; Matsunaga H; Kimura S
Med Oncol; 2017 Nov; 34(12):195. PubMed ID: 29124473
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of melphalan, arsenic trioxide and ascorbic acid combination therapy in patients with relapsed or refractory multiple myeloma: a prospective, multicentre, phase II, single-arm study.
Berenson JR; Boccia R; Siegel D; Bozdech M; Bessudo A; Stadtmauer E; Talisman Pomeroy J; Steis R; Flam M; Lutzky J; Jilani S; Volk J; Wong SF; Moss R; Patel R; Ferretti D; Russell K; Louie R; Yeh HS; Swift RA
Br J Haematol; 2006 Oct; 135(2):174-83. PubMed ID: 17010047
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of cisplatin-based highly emetogenic chemotherapy in patients with cancer: two randomised, active-controlled, double-blind, phase 3 trials.
Rapoport BL; Chasen MR; Gridelli C; Urban L; Modiano MR; Schnadig ID; Poma A; Arora S; Kansra V; Schwartzberg LS; Navari RM
Lancet Oncol; 2015 Sep; 16(9):1079-1089. PubMed ID: 26272769
[TBL] [Abstract][Full Text] [Related]
16. High-Dose Vitamin C in Advanced-Stage Cancer Patients.
Zasowska-Nowak A; Nowak PJ; Ciałkowska-Rysz A
Nutrients; 2021 Feb; 13(3):. PubMed ID: 33652579
[TBL] [Abstract][Full Text] [Related]
17. Phase I Clinical Trial of Intravenous L-ascorbic Acid Following Salvage Chemotherapy for Relapsed B-cell non-Hodgkin's Lymphoma.
Kawada H; Sawanobori M; Tsuma-Kaneko M; Wasada I; Miyamoto M; Murayama H; Toyosaki M; Onizuka M; Tsuboi K; Tazume K; Shirasugi Y; Ohmachi K; Ogawa Y; Kobayashi H; Ando K
Tokai J Exp Clin Med; 2014 Sep; 39(3):111-5. PubMed ID: 25248425
[TBL] [Abstract][Full Text] [Related]
18. Combination of intravenous ascorbic acid administration and hypothermia after resuscitation improves myocardial function and survival in a ventricular fibrillation cardiac arrest model in the rat.
Tsai MS; Huang CH; Tsai CY; Chen HW; Cheng HJ; Hsu CY; Chang WT; Chen WJ
Acad Emerg Med; 2014 Mar; 21(3):257-65. PubMed ID: 24628750
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Massage During Chemotherapy and/or Biotherapy Infusions: Patient Perceptions of Pain, Fatigue, Nausea, Anxiety, and Satisfaction.
Robison JG; Smith CL
Clin J Oncol Nurs; 2016 Apr; 20(2):E34-40. PubMed ID: 26991721
[TBL] [Abstract][Full Text] [Related]
20. Effect of high-dose intravenous ascorbic acid on cancer patients following ketogenic diet.
Sebastian S; Paul A; Joby J; Saijan S; Vilapurathu JK
J Cancer Res Ther; 2021; 17(6):1583-1586. PubMed ID: 34916403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
